Documenti analoghi: AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT /

Soggetto: Biomedical Engineering

Soggetto: This Thesis Paper of BME in BSc Program.